Portfolio Companies

Sort By:

Aptinyx

Aptinyx

Neurology | Clinical | IPO

Clinical company developing platform of neuromodulators for neurology indications.

Visit Site

×

Carisma Therapeutics

Carisma Therapeutics

Oncology | Preclinical | Active

Preclinical company developing immunotherapy platform for oncology applications.

Visit Site

×

Orbus Therapeutics

Orbus Therapeutics

Oncology | Clinical | Active

Clinical company developing therapeutics for rare brain tumors.

Visit Site

×
×

Orchard Therapeutics

Orchard Therapeutics

Rare Disease, Neurology, Immunology | Commercial | Active

Commercial company developing gene therapies for rare immunology disorders.

Visit Site

×

Palvella Therapeutics

Palvella Therapeutics

Rare Disease, Immunology | Clinical | Active

Clinical stage company developing therapeutics for rare dermatological disorders.

Visit Site

×

Pliant Therapeutics

Pliant Therapeutics

Rare Disease | Preclinical | Active

Preclinical company developing therapeutics targeting key biological pathways in fibrosis.

Visit Site

×
×

Precision Biosciences

Precision Biosciences

Rare Disease, Oncology | Preclinical | Active

Preclinical company developing gene-editing platform for oncology and rare diseases.

Visit Site

×

Skyhawk Therapeutics

Skyhawk Therapeutics

Rare Disease, Oncology, Neurology | Preclinical | Active

Preclinical company developing platform to correct RNA expression in neurology, oncology and rare diseases.

Visit Site

×

Verge Genomics

Verge Genomics

Neurology | Preclinical | Active

Preclinical company developing therapies for neurodegenerative diseases.

Visit Site

×
×
×